ti.\*:("Mechanisms and management of heart failure : implications of clinical trials for clinical practice. Symposium")
Results 1 to 25 of 28
Selection :
Abnormalities of baroreflex control in heart failureTHAMES, M. D; KINUGAWA, T; SMITH, M. L et al.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 56A-60A, issn 0735-1097, SUPAConference Paper
Atrial natriuretic peptide in heart failureBRANDT, R. R; WRIGHT, R. S; REDFIELD, M. M et al.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 86A-92A, issn 0735-1097, SUPAConference Paper
Diastolic dysfunction as a cause of heart failureLITWIN, S. E; GROSSMAN, W.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 49A-55A, issn 0735-1097, SUPAConference Paper
Factors contributing to the exercise limitation of heart failureWILSON, J. R; MANCINI, D. M.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 93A-98A, issn 0735-1097, SUPAConference Paper
Changes in myocardial and vascular receptors in heart failureBRISTOW, M. R.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 61A-71A, issn 0735-1097, SUPAConference Paper
Digoxin in heart failure : implications of recent trialsKELLY, R. A; SMITH, T. W.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 107A-112A, issn 0735-1097, SUPAConference Paper
The molecular biology of heart failureSCHWARTZ, K; CHASSAGNE, C; BOHELER, K. R et al.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 30A-33A, issn 0735-1097, SUPAConference Paper
Efficacy of vasodilators in the treatment of heart failureCOHN, J. N.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 135A-138A, issn 0735-1097, SUPAConference Paper
Relation of pathophysiologic mechanisms to outcome in heart failurePOOLE-WILSON, P. A.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 22A-29A, issn 0735-1097, SUPAConference Paper
The dysfunctional endothelium in heart failureTREASURE, C. B; ALEXANDER, R. W.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 129A-134A, issn 0735-1097, SUPAConference Paper
Exercise rehabilitation in chronic heart failureSTEWART, A. J.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 172A-177A, issn 0735-1097, SUPAConference Paper
Calcium channel blockers in heart failureURI ELKAYAM; AVRAHAM SHOTAN; ANILKUMAR MEHRA et al.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 139A-144A, issn 0735-1097, SUPAConference Paper
The epidemiology of heart failure : the Framingham studyHO, K. K. L; PINSKY, J. L; KANNEL, W. B et al.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 6A-13A, issn 0735-1097, SUPAConference Paper
Clinical trials of diuretic therapy in heart failure : research directions and clinical considerationsCODY, R. J.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 165A-171A, issn 0735-1097, SUPAConference Paper
Measurement of health-related quality of life in heart failureGUYATT, G. H.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 185A-191A, issn 0735-1097, SUPAConference Paper
Current and ongoing randomized trials in heart failure and left ventricular dysfunctionREKHA GARG; SALIM YUSUF.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 194A-197A, issn 0735-1097, SUPAConference Paper
Viral myocarditis : a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathySOLE, M. J; LIU, P.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 99A-105A, issn 0735-1097, SUPAConference Paper
Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failureFLORAS, J. S.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 72A-84A, issn 0735-1097, SUPAConference Paper
Perspective of the pharmaceutical industry on the development of new drugs for heart failureRAJFER, S. I.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 198A-200A, issn 0735-1097, SUPAConference Paper
Use of converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunctionPITT, B.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 158A-161A, issn 0735-1097, SUPAConference Paper
Role of converting enzyme inhibitors in the treatment of heart failureHOOD, W. B.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 154A-157A, issn 0735-1097, SUPAConference Paper
Role of surrogate end points in the evaluation of drugs for heart failureLIPICKY, R. J; PACKER, M.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 179A-184A, issn 0735-1097, SUPAConference Paper
The development of positive inotropic agents for chronic heart failure : how have we gone astray ?PACKER, M.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 119A-126A, issn 0735-1097, SUPAConference Paper
Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failureVATNER, S. F; HITTINGER, L.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 34A-40A, issn 0735-1097, SUPAConference Paper
Natural history and patterns of current practice in heart failureBOURASSA, M. G; GURNE, O; BANGDIWALA, S. I et al.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 14A-19A, issn 0735-1097, SUPAConference Paper